12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersPaxMedica (NASDAQ:PXMD) stock moved upwards by 104.2% to $0.84 during Friday's pre-market session. The market value of their outstanding shares is at $6.2 million. Allarity Therapeutics (NASDAQ
BenzingaApr 12 08:09 ET
Small-Cap Firm Century Therapeutics' Expands Into Autoimmune Diseases, Analyst Says Clade Therapeutics Acquisition Intriguing
Thursday, Century Therapeutics (NASDAQ:IPSC) unveiled plans to expand clinical development for its lead program, CNTY-101, a CD19-targeting iNK cell therapy, into additional autoimmune disease indicat
BenzingaApr 11 16:24 ET
Express News | Needham Reiterates Buy on Nkarta, Maintains $15 Price Target
Moomoo 24/7Apr 10 07:32 ET
Analysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Nkarta (NKTX)
TipRanksApr 10 07:00 ET
Nkarta to Participate in Upcoming Investor Conferences
PDF Version SOUTH SAN FRANCISCO, Calif., April 03, 2024 (GLOBE NEWSWIRE) -- Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer (NK) cell therapies, to
NkartaApr 3 00:00 ET
Nkarta(NKTX.US) Director Buys US$20 Million in Common Stock
$Nkarta(NKTX.US)$ Director George Simeon purchased 2 million shares of Common Stock on Mar 27, 2024 at an average price of $10 for a total value of $20 million.Source: Announcement What is statement o
moomoo NewsMar 28 23:19 ET
Promising Biopharma Nkarta (NASDAQ:NKTX) Not For the Faint-hearted
TipRanksMar 26 14:59 ET
TD Cowen Reaffirms Their Buy Rating on Nkarta (NKTX)
TipRanksMar 26 07:25 ET
Nkarta Is Maintained at Buy by Canaccord Genuity
Nkarta Is Maintained at Buy by Canaccord Genuity
Dow JonesMar 26 07:17 ET
Express News | Canaccord Genuity Maintains Buy on Nkarta, Raises Price Target to $16
Moomoo 24/7Mar 26 07:07 ET
Stifel Nicolaus Keeps Their Buy Rating on Nkarta (NKTX)
TipRanksMar 25 22:05 ET
Unlocking The Momentum: Nkarta (NKTX) Stock On The Rise
The current surge in Nkarta, Inc. (NASDAQ: NKTX) shares on the US stock market indicates a remarkable increase of 22.42%, reaching $10.92 per share at the last check. This notable upswing in NKTX stock value is attributed to a strategic equity maneuver. In an underwritten offering of 21,010,000 shares of its common stock, Nkarta (NKTX) ...
Stocks TelegraphMar 25 13:10 ET
Nkarta Is Maintained at Buy by HC Wainwright & Co.
Nkarta Is Maintained at Buy by HC Wainwright & Co.
Dow JonesMar 25 12:44 ET
HC Wainwright & Co. Maintains Buy on Nkarta, Raises Price Target to $22
HC Wainwright & Co. analyst Emily Bodnar maintains Nkarta (NASDAQ:NKTX) with a Buy and raises the price target from $20 to $22.
BenzingaMar 25 12:33 ET
Nkarta Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/25/2024 109.72% HC Wainwright & Co. $20 → $22 Maintains Buy 03/22/2024 138.32% Mizuho $31 → $25 Maintai
BenzingaMar 25 12:33 ET
Crude Oil Moves Higher; US New Home Sales Fall In February
U.S. stocks traded lower midway through trading, with the Dow Jones index falling more than 100 points on Monday. The Dow traded down 0.22% to 39,389.17 while the NASDAQ fell 0.15% to 16,410.10. The S
BenzingaMar 25 11:54 ET
Nkarta, Nuvation Bio, Canopy Growth Among Healthcare Movers
Seeking AlphaMar 25 10:00 ET
12 Health Care Stocks Moving In Monday's Pre-Market Session
GainersLandos Biopharma (NASDAQ:LABP) shares moved upwards by 181.6% to $22.05 during Monday's pre-market session. The market value of their outstanding shares is at $68.7 million. As per the press re
BenzingaMar 25 09:05 ET
Express News | Nkarta Shares Are Trading Higher After the Company Priced $240 Million Underwritten Offering
Moomoo 24/7Mar 25 06:45 ET
Express News | Nkarta Prices Its Underwritten Offering Of 21M Shares At $10.00/Share And Pre-funded Warrants To Purchase 3M Shares At $9.9999/Warrant, With Gross Proceeds Of Approximately $240.1M
Moomoo 24/7Mar 25 06:34 ET
No Data
No Data